Monoclonal Antibodies
Stronger Punch?
Monoclonal antibodies provide new hope for easier dosing
by Jeannie Wraight
With multi-drug, once-a-day therapies now available for use, the push for additional easier to...
When in Rome
The 6th IAS Pathogenesis Conference doesn't really end after the closing session
by David Miller
In 1987 I attended my first AIDS conference, beginning twenty-four years...
Sweet Heart
A statin challenges the drug interaction status quo
by Chael Needle
LifeGuide
Maintaining appropriate levels of lipids (fats or fat-like substances in the blood)—“good” cholesterol (HDL-C),...
Old Concept, New Hope
LifeGuide
Therapeutic Vaccines May Change the Treatment Landscape for the Better
by Jeannie Gibbs
Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...
A Shot in the Dark
Therapeutic Vaccine Research Toward a Functional Cure Shows Promise
by Jeannie Wraight
Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...
Safety Net
Treatment Horizons by Chael Needle
A nonprofit creates a new support system for the uninsured
Joining Merck and ViiV Healthcare, Gilead Sciences is now supporting and...
Alisson Sombredero, MD
Not So Complicated
Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care
by Chael Needle
Alisson Sombredero, MD, is more than two months into her...
Preventative HIV Vaccine
Express Lane
A Vaccine Candidate Seeks to Prevent—Not Just Control—HIV Infection
by Chael Needle
Preventative HIV vaccine research has taken another step.
The candidate, a granulocyte-macrophage colony stimulating factor...
Early Bird
Study results show immediate treatment holds promise as a prevention tool
by Chael Needle
Treatment and prevention make good bedfellows. That’s the idea underscoring the results...
Listen with Care
Natasha Travis, MD, helps shape the HIV learning curve for physicians and patients
by Chael Needle
Awarded a 2012 Minority Clinical Fellowship by the HIV Medicine...